Researchers have significantly boosted the progress of an new treatment for ATTR-CM, employing the investigational drug. Preliminary clinical data reveals promising outcomes for patients affected with the severe https://bridgebio335874.blogdal.com/42543298/company-improves-cardiac-amyloidosis-treatment-through-attruby